Skip navigation
Speakers

Innovative Pharmacy and Distribution Models Driven by Market Dynamics, Product Type, Site of Care and Reimbursement

December 3-5, 2019
  • Philadelphia, PA

Allison Bridges
Director, Access and Trade
kaléo

John Campo
Vice President, Commercial Channels
Boston Scientific

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

J’Aime Conrod, MSPH
Head of Specialty Markets, Market Access and Pricing
UCB, Inc.

Diana Dai
Executive Director, US Pipeline and Launch Management
Sandoz

Michael Diaco
Assistant General Counsel
Pfizer

Sean Duffy
Principal Consultant
Blue Fin Group

Marc Duey
CEO and President
ProMetrics LLC

Adam J. Fein, PhD
CEO
Drug Channels Institute

Rich Gourash
Vice President, Specialty Outcomes
Therigy

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

Eric D. Hargan
Deputy Secretary
Department of Health and Human Services (HHS)

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Bob Jones
Managing Director
Goldman Sachs

Paul Maurer
Senior Consultant
Protean LLC

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

Mark Polidoro
Director, Consulting Services
ValueCentric

Donovan Quill
President & CEO
Optime Care Inc.

Bob Raffo
President and CEO
FirstView

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

William Roth
Founding Partner
Blue Fin Group

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

Mike Steelman
Vice President, Market Access
TherapueticsMD

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

Shannon Wiley
Attorney
Bass Berry & Sims PLC

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes

Allison Bridges
Director, Access and Trade
kaléo

John Campo
Vice President, Commercial Channels
Boston Scientific

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

J’Aime Conrod, MSPH
Head of Specialty Markets, Market Access and Pricing
UCB, Inc.

Diana Dai
Executive Director, US Pipeline and Launch Management
Sandoz

Michael Diaco
Assistant General Counsel
Pfizer

Sean Duffy
Principal Consultant
Blue Fin Group

Marc Duey
CEO and President
ProMetrics LLC

Adam J. Fein, PhD
CEO
Drug Channels Institute

Rich Gourash
Vice President, Specialty Outcomes
Therigy

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

Eric D. Hargan
Deputy Secretary
Department of Health and Human Services (HHS)

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Bob Jones
Managing Director
Goldman Sachs

Paul Maurer
Senior Consultant
Protean LLC

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

Mark Polidoro
Director, Consulting Services
ValueCentric

Donovan Quill
President & CEO
Optime Care Inc.

Bob Raffo
President and CEO
FirstView

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

William Roth
Founding Partner
Blue Fin Group

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

Mike Steelman
Vice President, Market Access
TherapueticsMD

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

Shannon Wiley
Attorney
Bass Berry & Sims PLC

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes